![](/img/cover-not-exists.png)
Human non-small cell lung cancer (NSCLC) cell lines with inactivated LKB1 and KRAS mutations are sensitive to MEK inhibition
C. Mahoney, B. Choudhury, H. Davies, G. Bignell, M. Stratton, A. FutrealVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)71300-4
File:
PDF, 97 KB
english, 2008